首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥硝唑氯化钠注射液与注射用头孢西丁钠配伍稳定性考察
引用本文:张敬阳,郑芳,朱雪松.奥硝唑氯化钠注射液与注射用头孢西丁钠配伍稳定性考察[J].中国医药,2010,6(8):436-438.
作者姓名:张敬阳  郑芳  朱雪松
作者单位:湖北医药学院附属东风医院口腔科,湖北省十堰市,442008;湖北医药学院附属东风医院药剂部,湖北省十堰市,442008;
摘    要:目的 考察室温(20±1)℃]下,奥硝唑氯化钠注射液与注射用头孢西丁钠配伍的稳定性,为临床合理用药提供科学依据.方法 采用反相高效液相色谱法-二极管阵列检测器同时测定配伍液中奥硝唑与头孢西丁钠0~6 h内的含量变化,并观察配伍液的外观及pH.结果 奥硝唑与头孢西丁钠的检测波长分别为318、237 nm;奥硝唑与头孢西丁钠的回归方程分别为Y奥=0.7444 X奥+3.0667(r=0.9998,n=6)和Y西=0.6549 X西+6.2667(r=0.9996,n=6),结果 表明在奥硝唑50.8~304.8 mg/L、头孢西丁钠101.6~609.6 mg/L浓度范围内与峰面积呈良好的线性关系;精密度试验测得奥硝唑峰面积相对标准偏差(RSD)为0.58%;头孢西丁钠峰面积RSD为0.65%;重复性试验测得奥硝唑峰面积RSD为0.84%;头孢西丁钠峰面积RSD为0.92%;稳定性试验测得奥硝唑与头孢西丁钠峰面积RSD分别为0.52%、0.89%.6 h内配伍液外观、pH及含量均无明显变化.结论 在室温条件下,奥硝唑氯化钠注射液与注射用头孢西丁钠6 h内可以配伍使用.

关 键 词:奥硝唑    头孢西丁    色谱法  高压液相    药物配伍禁忌    药物稳定性    

Stability of cefoxitin sodium for injection mixed with ornidazole and sodium chloride injection
ZHANG Jing-yang,ZHENG Fang,ZHU Xue-song.Stability of cefoxitin sodium for injection mixed with ornidazole and sodium chloride injection[J].China Medicine,2010,6(8):436-438.
Authors:ZHANG Jing-yang  ZHENG Fang  ZHU Xue-song
Abstract:Objective To study the stability of cefoxitin sodium for injection and omidazole and sodium chloride injection at ambient temperature, in order to provide a scientific basis for rational use of drug in clinical practice. Methods The changes of the contents of cefoxitin and ornidazole were determined simultaneously by RPHPLC-DAD, and the changes of appearance, pH values were observed within 6 hours. Results The detection wave lengths were 318 nm, 237 nm for ornidazole and cefoxitin, the calibration equation was Y0 = 0. 7444X0 + 3.0667 (r =0.9998, n = 6) for ornidazole and Yce = 0. 6549Xce + 6.2667 ( r = 0. 9996, n = 6) for cefoxitin. No significant changes were noted in the contents, appearance and pH value for the mixed solution within 6 hours. Conclusion Cefoxitin sodium for injection can be mixed with ornidazole and sodium chloride injection at ambient temperature within 6 hours.
Keywords:OrnidazoleCefoxitinChromatography  high pressure liquidDrug incompatibilityDrug stability
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号